“Arguing that you don’t care about the right to privacy because you have nothing to hide is no different than saying you don’t care about free speech because you have nothing to say.”

– Edward Snowden


We are the UK Freedom Project.

Our website address is:

You can contact us by emailing or by using the form on our Contact page.


We like to keep things simple.

Your data is your data.

We don’t want it.

We don’t ask for it (unless you choose to use our contact form) and we don’t sneakily collect it from you while you aren’t looking.

We don’t track where you are, where on the internet you’ve come from or where you go after you leave our site.

We don’t ask you to subscribe to our blog or sign up to a mailing list (so you don’t have to give us your email etc).

We don’t ask for comments on our blog posts (for the same reason).

We don’t ask you to share our posts or pages (again for the same reason) – but we hope that you will.


Embedded Content From Other Websites

Every now and then, we may include embedded content (e.g. a YouTube video) in a blog article.

Embedded content from other websites behaves in the exact same way as if you have visited the other website.

These websites may collect data about you, use cookies, embed additional third-party tracking, and monitor your interaction with that embedded content, including tracking your interaction with the embedded content if you have an account and are logged in to that website.

Wherever possible, we will host our own copy of a video, but sometimes it just isn’t possible due to copyright or the size of the file involved. If we use embedded content, we will put a notice immediately before it so that you can choose whether you wish to interact with it.

Taking Action on Campaigns

We want you to get involved in our campaigns and take important actions that help exercise and protect your freedoms.  But in order to do that, you may need to visit third party websites.

Different websites may collect different data from you. They may track you in different ways. It is important that before you interact with a website that we have directed you to in order to take action, that you have a look through their privacy policy and ensure you are happy to provide them with the data needed.

We don’t track which campaigns you take action on and we don’t receive any information from the third party websites about whether or how you interacted with them.

Social Media

As we said, we don’t insist that you share any content from our website. But if you do want to share something, all you need to do is copy the URL (the website address) for the page or post then paste it into whichever social media platform or email client you use. We won’t know that you’ve done it – but bear in mind that the social media platform will.

We have a presence on several social media platforms. It is the main way that we disseminate important information to as wide an audience as possible. If you choose to follow us and/or interact with us on any of the social media platforms, be aware that the platform will collect and keep data about that interaction. But we don’t – other than what the platform concerned tells us in our user account e.g. who has retweeted a tweet. We don’t use any fancy marketing and remarketing tools to analyse how you interact with us or stalk you around the internet.


No-one – absolutely no-one at all.


We can’t keep what we don’t have. So unless you have used our contact form, we don’t have anything to retain. If you have used our contact form, we will keep the information from that contact and any subsequent follow up conversation for as long as is appropriate (e.g. until we have answered your query).


You have all rights over your data and we have none. If you have used our contact form and wish us to delete the information provided in that conversation, just email and we will delete it.

Essential Context for Understanding this report

These reports contain a complete listing of all suspected adverse reactions that have been reported to the MHRA via the Yellow Card scheme for COVID-19 vaccines. This includes all reports received from healthcare professionals, members of the public, and pharmaceutical companies.

This information does not represent an overview of the potential side effects associated with the vaccines. A list of the recognised adverse effects of the COVID-19 vaccines is provided in the information for healthcare professionals and the recipient information here. Conclusions on the safety and risks of the vaccines cannot be made on the data shown in the report alone. When viewing the report, you should remember that:

  • Reporters are asked to submit Yellow Card reports even if they only have a suspicion that the vaccine may have caused the adverse reaction. The existence of an adverse reaction report does not necessarily mean that the vaccine has caused the reaction.

  • It may be difficult to tell the difference between something that has occurred naturally and an adverse reaction. Sometimes reactions can be part of the condition being treated rather than being caused by the vaccine.

  • Many factors have to be considered when assessing whether a vaccine has caused a reported adverse reaction. When monitoring the safety of medicines and vaccines, MHRA staff carry out careful analysis of these factors.

  • It is not possible to compare the safety of different vaccines by comparing the numbers presented in the vaccine reports. Reporting rates can be influenced by many factors including the seriousness of the adverse reactions, their ease of recognition and the extent of use of a particular vaccine. Reporting can also be stimulated by promotion and publicity about a product.

For a vaccine to be considered safe, the expected benefits will be greater than the risk of having harmful reactions. It is important to note that most people receive vaccinations without having any serious side effects.

Risks and benefits of medicines

For a medicine to be considered safe, the expected benefits of the medicine will be greater than the risk of suffering harmful reactions. It is important to note that most people take medicines without suffering any serious side effects.

All medicines can cause reactions. The patient information leaflet accompanying the medicine, or available from your pharmacist, lists the known side effects associated with the medicine. Healthcare professionals such as doctors and pharmacists can also provide this information. Information on side effects of medicines can be found on the NHS website.

Monitoring the safety of medicines and vaccines

Information collected through the Yellow Card scheme is an important tool in helping the MHRA and CHM monitor the safety of medicines. Yellow Card reports of suspected adverse reactions are evaluated, together with additional sources of evidence such as worldwide literature, in order to identify previously unidentified hazards or side effects.

If a new side effect is identified, information is carefully considered in context of the overall side effect profile for the medicine or vaccine, and how it compares with other medicines used to treat the same condition.

The MHRA will take action, if necessary, to ensure that the product is used in a way that minimises risk, while maximising patient benefit. Such changes may include, for example, restricting the indication, or special warnings and precautions. Rarely, a drug may need to be withdrawn from the market if the risk of side effects is considered to outweigh the benefits of treatment. Please see our How we monitor the safety of medicines section for further information.

Use of Yellow Card data for publication

If you wish to copy or circulate the information contained within a report to anyone else, please ensure that a copy of these guidelines is also provided.

The MHRA and CHM encourage the use of data from the Yellow Card scheme in research and for publication, but wish to ensure that the limitations of interpretation of the data are made clear.

If you propose to publish information based on Yellow Card data, the MHRA is most willing to provide advice on how the Yellow Card information might be best used and presented. The MHRA is also willing to provide feedback on manuscripts prior to publication. Please write to the Deputy Director, Safety and Surveillance Group by email.